Common antidepressant may ease long COVID’s crushing fatigue
Published: 2026-07-21 • Permanent link
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue.
In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of t...
More details are emerging as this story continues to develop. Stay with Banking With Billy for ongoing coverage and analysis.
Why it matters: A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo...
🌎 Banking With Billy Network — All Sites
👤 About the Author
Billy Odell Tucker-Robinson is the founder and host of Banking With Billy, an independent financial intelligence platform covering markets, stocks, AI, crypto, and world news. Billy operates a 24/7 live AI radio and Stock TV platform, hosts a growing Discord community, and produces daily content on YouTube @BankingWithBilly.
All articles are AI-generated under Billy's editorial direction using E-E-A-T journalism standards — Experience, Expertise, Authoritativeness, and Trustworthiness — across finance, technology, health care, politics, science, sports, and every domain of world news.
Contact: billyotucker@gmail.com • 660-441-4905